Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.39−0.04 (-2.80%)
Close on Nov 19, 2026Market cap $52.02MP/E –Yield –
Tenax Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Tenax Therapeutics's free cash flow for the twelve months ending Jun 30, 2023 was -$7.67M. For fiscal 2022 it was -$11.39M. The highest annual figure on record is -$4.94M in fiscal 2013.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$11.39M | – |
| FY2021 | Dec 31, 2021 | -$10.86M | – |
| FY2020 | Dec 31, 2020 | -$9.28M | – |
| FY2019 | Dec 31, 2019 | -$7.56M | – |
| FY2018 | Dec 31, 2018 | -$5.51M | – |
| FY2017 | Dec 31, 2017 | -$12.15M | – |
| FY2015 | Apr 30, 2015 | -$9.75M | – |
| FY2014 | Apr 30, 2014 | -$9.27M | – |
| FY2013 | Apr 30, 2013 | -$4.94M | – |
| FY2012 | Apr 30, 2012 | -$8.30M | – |
| FY2011 | Apr 30, 2011 | -$8.64M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$924.57K | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$1.73M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$1.68M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$3.33M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$3.43M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$2.94M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$2.77M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$3.02M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$1.85M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$3.22M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$1.99M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$2.39M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$2.23M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$2.67M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$1.73M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$1.78M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$1.91M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$2.14M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$1.20M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$1.56M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$1.19M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$1.56M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | -$1.28M | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | -$1.23M | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | -$5.60M | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | -$4.04M | – |
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | -$1.63M | – |
| Q3 FY2015CQ4 2014 | Jan 31, 2015 | -$3.23M | – |
See a number that looks wrong?